This is example text for design purposes...Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
NWHN Policy Advocacy Director Sarah Christopherson provides a top-level overview of the ACA, how it helped women gain comprehensive health coverage, some exciting advances made in the Biden COVID relief package, and what challenges and opportunities lies ahead.
We’re excited to make progress on COVID relief, the ACA, and more, but deeply shaken by yesterday’s violent insurrection, incited by the president of the United States.
The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.
This research brief examines some of the most common waiver provisions attempted by states and spells out what each means for women as advocates and policymakers work to close the coverage gap.
In 2013, the Texas state legislature enacted House Bill 2 (HB 2), one of the most draconian anti-abortion measures in the country. Among other provisions, it applied hospital-like building codes to any clinic providing abortion services, and required doctors who provide abortions to have admitting privileges at a hospital within 30 miles from where they perform the procedure.
Once again, a provision of the Affordable Care Act (ACA) is being challenged before the Supreme Court, with oral arguments for Zubik v. Burwell scheduled for March 23. And once again the question at the heart of the case is whether women will have access to the contraception coverage assured them by the ACA even if their bosses have religious objections to birth control.
This research brief examines some of the most common waiver provisions attempted by states and spells out what each means for women as advocates and policymakers work to close the coverage gap.
Food and Drug Administration Safety and Innovation Act 907 Public Meeting: Progress on Enhancing the Collection, Analysis, and Availability of Demographic Subgroup Data
Sarah Christopherson was the NWHN’s Policy Advocacy Director from 2016 to 2021, responsible for directing the organization’s legislative, regulatory, and judicial advocacy efforts and managing the policy team. She served as the NWHN’s primary issue area expert on federal health reform implementation and defense, drug and device safety and efficacy, and sexual and reproductive health. She also directed federal policy initiatives for Raising Women’s Voices (RWV). She was quoted on behalf of the NWHN in the New York Times, Washington Post, CNN, USA Today, Reuters, Cosmopolitan, Rewire, Prevention, Yahoo News, Vice, ABC News San Francisco, and other print, TV, and radio outlets.
Prior to joining the NWHN, Sarah worked for Congress from 2005 to 2015, including serving as the Washington Director/Legislative Director to Congresswoman Niki Tsongas (D-MA), where she directed the Member’s legislative agenda and supervised her DC-based staff of eight. Over the course of her career, Sarah staffed every issue area that comes before the federal government, with in-depth knowledge of health policy, tax policy, financial services and banking, consumer protection, and the federal budget. Her experience includes work on the Affordable Care Act, Medicaid, Medicare, reproductive health, and the impact of banking and tax policy on income inequality, among other areas. Her legislative accomplishments include provisions enacted into law in the Dodd-Frank Wall Street Reform and Consumer Protection Act, Small Business Innovation Research reauthorization, and multiple National Defense Authorizations. She has a Bachelor of Science degree in political science and a Bachelor of Arts degree in history from Arizona State University and a Master of Arts degree in foreign policy from George Washington University.
